Stockreport

VYNE Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference

VYNE Therapeutics Inc.  (VYNE) 
PDF BRIDGEWATER, N.J., Feb. 21, 2024 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company develo [Read more]